Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
European thirst for tequila aggravates agave crunch
-
European thirst for tequila aggravates agave crunch
-
European thirst for tequila aggravates agave crunch
-
European thirst for tequila aggravates agave crunch
-
European thirst for tequila aggravates agave crunch
-
European thirst for tequila aggravates agave crunch
-
European thirst for tequila aggravates agave crunch
-
European thirst for tequila aggravates agave crunch
-
Airports, airlines rein in summer plans to avoid repeat of last year's chaos
-
Form 4 Airbnb, Inc. For: Feb 21 Filed by: Bernstein David C
-
Form 4 VECTOR GROUP LTD For: Feb 21 Filed by: BERNSTEIN RONALD J
-
Disney+ Debuts Trailer and Key Art for Music Docu-Special, ‘Bono & The Edge: A Sort of Homecoming, With Dave Letterman’ Premiering on Friday, March 17
-
Drake University announces $3.15 million philanthropic commitment from Sammons Financial Group
-
Form 4 CARNIVAL PLC For: Feb 21 Filed by: Bernstein David
-
Form 4 CARNIVAL CORP For: Feb 21 Filed by: Bernstein David
-
TelevisaUnivision Announces Q4 and Full Year 2022 Results
-
Balto Introduces Real-Time Notetaker to Eliminate After-Call Work, Increase Agent Efficiency
-
Bel Reports Fourth Quarter and Full Year 2022 Results
-
Form 4 ACADIA REALTY TRUST For: Feb 17 Filed by: BERNSTEIN KENNETH F
-
The Hartford Declares Quarterly Dividends Of $0.425 Per Share Of Common Stock And $375 Per Share Of Series G Preferred Stock
-
Synaptics to Participate at Upcoming Investor Conferences Wednesday, March 1, 2023 and Thursday, March 2, 2023
-
Cruelty-Free Subscription Box, Kinder Beauty, Launches First Skincare Line with Release of Vegan Serums!
-
New Relic to Participate in Upcoming Investor Conferences
-
Bernstein expects low-cost platform details at Tesla’s (TSLA) investor day
-
Form 4 Codiak BioSciences, Inc. For: Feb 16 Filed by: Bernstein Karen
-
SBA Communications (SBAC) Announces CEO Succession Plan
-
SBA Communications Corporation Announces CEO Succession Plan
-
Lieff Cabraser, Peiffer Wolf, and Meyer Wilson file federal class action against Norfolk Southern over February 3, 2023 Train Derailment and Massive Toxic Discharge
-
Starbucks (SBUX) path to full recovery will be hard argues Bernstein
-
Apple (AAPL) services weakness driven by softness in advertising and the app store
-
Allogene Therapeutics to Report Fourth Quarter and Year-End 2022 Financial Results on February 28, 2023
-
Allogene Therapeutics to Report Fourth Quarter and Year-End 2022 Financial Results on February 28, 2023
-
Aquestive Therapeutics (AQST) to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109
-
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109 Epinephrine Sublingual Film at American Academy of Allergy, Asthma, and Immunology (AAAAI)
-
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109 Epinephrine Sublingual Film at American Academy of Allergy, Asthma, and Immunology (AAAAI)
-
SHC INVESTOR ALERT: 3/27/2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
-
PLDT Inc. INVESTOR ALERT: 4/7/2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
-
Analysis-To raise prices or not? Consumer goods makers weigh bets while retailers fret
-
Form 4 Airbnb, Inc. For: Feb 15 Filed by: Bernstein David C
-
Man accused of targeting Jews in Los Angeles shootings charged with hate crimes
-
Bernstein starts MongoDB (MDB) at Outperform, says growth cloud surprise on the upside
-
Analysts discuss key takeaways from Snap's 2023 Investor Day
-
Hermes beats forecasts on robust growth in China, U.S.
-
Mercedes-Benz eyes more direct sales amid earnings pressure
-
Form 4 Equitable Holdings, Inc. For: Feb 15 Filed by: BERNSTEIN SETH P
-
SHC INVESTORS: March 27, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
-
Maze Therapeutics to Present Phase 1 Results from First-in-Human Trial Evaluating MZE001 as a Potential Oral Treatment for Pompe Disease at the WORLDSymposium 2023
-
PLDT Inc. INVESTORS: April 7, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
-
Gucci banks on private 'salons' for the ultra-rich to revive sales
-
Mercedes-Benz to buy back up to 4 billion euros in shares by 2025

